Inhibition of human non-small cell lung tumors by a c-Met antisense/U6 expression plasmid strategy.
about
Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell deathc-Met as a Target for Personalized TherapyHGF-independent potentiation of EGFR action by c-MetHGF and c-Met participate in paracrine tumorigenic pathways in head and neck squamous cell cancerTherapeutic targeting of receptor tyrosine kinases in lung cancer.DNA triplex-mediated inhibition of MET leads to cell death and tumor regression in hepatoma.Therapeutic targeting of human hepatocyte growth factor with a single neutralizing monoclonal antibody reduces lung tumorigenesisRole of transglutaminase 2 in liver injury via cross-linking and silencing of transcription factor Sp1MET as a target for treatment of chest tumorsInsulin-like growth factor-1 receptor-targeted therapy for non-small cell lung cancer: a mini reviewClinical implications of MET gene copy number in lung cancer.Selection criteria for c-Met-targeted therapies: emerging evidence for biomarkers.Phosphotyrosine profiling of NSCLC cells in response to EGF and HGF reveals network specific mediators of invasion.Interaction of actinomycin D with promoter element of c-met and its inhibitory effect on the expression of c-Met.Suppression of epidermal growth factor receptor (EGFR) expression by small hairpin RNA inhibits the growth of human nonsmall cell lung cancers bearing wild-type and mutant EGFR.Epidermal growth factor receptor regulates MET levels and invasiveness through hypoxia-inducible factor-1alpha in non-small cell lung cancer cells.Inhibition of c-Met as a therapeutic strategy for esophageal adenocarcinoma.
P2860
Q24610879-3697F535-D572-4DA2-8896-AF0E0B38145FQ26775483-CB8D3263-3F25-42E5-8535-CFBDF687F9C8Q35078530-5CF6D248-20A8-42D2-A3C5-F137B4DDE5B4Q35174872-ED09514F-B405-4310-8ED2-08D1731DF523Q36158717-29ACF4AC-DBB9-465F-8DD3-3D7A3BEBB9EAQ36868117-362B69E0-E68F-4508-90C2-F6F8BE2B8E5BQ36915616-FDEA0AA4-45F7-4FFC-9F89-5442BF569354Q37124999-F84A5355-A827-444A-A7D9-6F161C59182FQ37232416-AFCE3673-5FC1-4609-BEB5-13C23FA2B422Q37418930-25D3EF8D-2702-44C6-BFD8-CEC2B8DA7F2AQ37690299-8F8C439B-4714-4FAF-93D1-FC4F9206E128Q37730020-E67E964B-6D92-4031-B7C9-876046EE269EQ38257674-FD26FDE8-A12F-4026-A42C-066C45334206Q38356393-6890457E-A542-47E6-9E96-DEAD87C0B854Q39442801-9F33D615-FD51-41EA-B00C-308107736348Q39739616-D9487597-B823-4C24-A80B-694109C1E995Q40203442-09B05F0A-A808-4835-9D10-5FC17A744DD9
P2860
Inhibition of human non-small cell lung tumors by a c-Met antisense/U6 expression plasmid strategy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Inhibition of human non-small ...... 6 expression plasmid strategy.
@en
Inhibition of human non-small ...... 6 expression plasmid strategy.
@nl
type
label
Inhibition of human non-small ...... 6 expression plasmid strategy.
@en
Inhibition of human non-small ...... 6 expression plasmid strategy.
@nl
prefLabel
Inhibition of human non-small ...... 6 expression plasmid strategy.
@en
Inhibition of human non-small ...... 6 expression plasmid strategy.
@nl
P2093
P2860
P356
P1433
P1476
Inhibition of human non-small ...... 6 expression plasmid strategy.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.GT.3302169
P577
2004-02-01T00:00:00Z
P5875
P6179
1012517772